National Center for Complementary and Alternative Medicine Announcement of Workshop on Control/Comparison Groups for Trials of Non-Pharmacologic Interventions, 12769-12770 [2010-5767]
Download as PDF
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Federal Register / Vol. 75, No. 51 / Wednesday, March 17, 2010 / Notices
Conference Centers, 3501 University
Blvd. East, Adelphi, MD. The hotel
telephone number is 301–985–7300.
Contact Person: Diem-Kieu Ngo,
Center for Drug Evaluation and Research
(HFD–21), Food and Drug
Administration, 5600 Fishers Lane (for
express delivery, 5630 Fishers Lane, rm.
1093), Rockville, MD 20857, 301–827–
7001, FAX: 301–827–6776, email:
diem.ngo@fda.hhs.gov, or FDA
Advisory Committee Information Line,
1–800–741–8138 (301–443–0572 in the
Washington, DC area), code
3014512543. Please call the Information
Line for up-to-date information on this
meeting. A notice in the Federal
Register about last minute modifications
that impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
should always check the agency’s Web
site and call the appropriate advisory
committee hot line/phone line to learn
about possible modifications before
coming to the meeting.
Agenda: On May 6, 2010, the
committee will discuss supplemental
new drug application (sNDA) 22–432,
H.P. ACTHAR Gel (repository
corticotropin injection), 80 USP units
per milliliter, Questcor Pharmaceuticals,
proposed for the treatment of infantile
spasms.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before April 22, 2010. Oral
presentations from the public will be
scheduled between approximately 11
a.m. and 12 noon. Those desiring to
make formal oral presentations should
notify the contact person and submit a
brief statement of the general nature of
the evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before April 14, 2010. Time allotted
for each presentation may be limited. If
VerDate Nov<24>2008
15:08 Mar 16, 2010
Jkt 220001
the number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by April 15, 2010.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact Diem-Kieu
Ngo at least 7 days in advance of the
meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/Advisory
Committees/AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: March 11, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2010–5813 Filed 3–16–10; 8:45 am]
12769
Emphasis Panel; HLA Region Genetics in
Immune-Mediated Diseases.
Date: April 7–8, 2010.
Time: 8 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crowne Plaza Hotel—Silver Spring,
8777 Georgia Avenue, Silver Spring, MD
20910.
Contact Person: Maryam Feili-Hariri, PhD,
Scientific Review Officer, Immunology
Review Branch, Scientific Review Program,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–5658, haririmf@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 10, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–5769 Filed 3–16–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary
and Alternative Medicine
Announcement of Workshop on
Control/Comparison Groups for Trials
of Non-Pharmacologic Interventions
ACTION:
Notice.
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
SUMMARY: The National Center for
Complementary and Alternative
Medicine (NCCAM) invites the public to
participate at a Workshop on the choice
of control and comparison groups for
trials of non-pharmacological
interventions (NPI). The purpose of this
workshop is to review the strengths and
weaknesses of the various control/
comparison groups used in studies of
NPI and the most appropriate use of
these control/comparison groups. This
workshop will be divided into six
sessions that will feature presentations
and discussions focusing on the
selection of a particular control/
comparison group(s) for a given research
question. The first session will provide
case studies from the NPI literature,
while the remainder will address the
choice of control/comparison groups
when researching the following
questions: What is/are the major active
component(s) of the NPI? What is/are
the major effective mechanism(s) of the
NPI? Does this NPI work at all? Is this
NPI as good as (or better than) some
other intervention? Does this NPI
improve standard-of-care?
E:\FR\FM\17MRN1.SGM
17MRN1
12770
Federal Register / Vol. 75, No. 51 / Wednesday, March 17, 2010 / Notices
The Workshop will take place on
April 26–27, 2010 in Rockville,
Maryland. Seating is limited.
Background: The National Center for
Complementary and Alternative
Medicine (NCCAM) was established in
1998 with the mission of exploring
complementary and alternative healing
practices in the context of rigorous
science, training CAM researchers, and
disseminating authoritative information
to the public and professionals.
To date, NCCAM’s efforts to
rigorously study CAM, to train CAM
researchers, and to communicate with
the public and professionals, have been
guided by NCCAM’s previous strategic
plans, located on the NCCAM Web site
at https://nccam.nih.gov/about/plans.
The Workshop will take place on
April 26–27, 2010 in Rockville,
Maryland. Seating is limited.
FOR FURTHER INFORMATION CONTACT: To
request more information, visit the
NCCAM Web site at https://
nccam.nih.gov, call Edward Culhane at
301–594–3391, or e-mail
culhanee@mail.nih.gov.
Dated: March 9, 2010.
Richard Nahin,
Senior Advisor for Scientific Coordination
and Outreach, National Center for
Complementary and Alternative Medicine,
National Institutes of Health.
clearance in accordance with the
requirements of the Paperwork
Reduction Act of 1995. The submission
describes the nature of the information
collection, the categories of
respondents, the estimated burden (i.e.,
the time, effort and resources used by
respondents to respond) and cost, and
the actual data collection instruments
FEMA will use.
DATES: Comments must be submitted on
or before April 16, 2010.
ADDRESSES: Submit written comments
on the proposed information collection
to the Office of Information and
Regulatory Affairs, Office of
Management and Budget. Comments
should be addressed to the Desk Officer
for the Department of Homeland
Security, Federal Emergency
Management Agency, and sent via
electronic mail to
oira.submission@omb.eop.gov or faxed
to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
should be made to Director, Office of
Records Management, 1800 South Bell
Street, Arlington, VA 20598–3005,
facsimile number (202) 646–3347, or email address FEMA-InformationCollections@dhs.gov.
[FR Doc. 2010–5767 Filed 3–16–10; 8:45 am]
SUPPLEMENTARY INFORMATION:
BILLING CODE 4140–01–P
Collection of Information
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2009–0001]
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request, OMB No.
1660—NEW; Regional Catastrophic
Preparedness Grant Program (RCPGP)
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice; 30-day notice and
request for comments; new information
collection; OMB No. 1660—NEW;
FEMA Form FEMA Form 089–19,
RCPGP Investment Justification
Template; FEMA Form 089–26, RCGCP
(Sample) Detailed Project Plan
Template; FEMA Form 089–17, RCPT
Membership List.
SUMMARY: The Federal Emergency
Management Agency (FEMA) has
submitted the information collection
abstracted below to the Office of
Management and Budget for review and
VerDate Nov<24>2008
15:08 Mar 16, 2010
Jkt 220001
Title: FEMA Preparedness Grants:
Regional Catastrophic Preparedness
Grant Program (RCPGP).
Type of information collection: New
information collection.
OMB Number: 1660—NEW.
Form Titles and Numbers: FEMA
Form 089–19, RCPGP Investment
Justification Template; FEMA Form
089–26, RCGCP (Sample) Detailed
Project Plan Template; FEMA Form
089–17, RCPT Membership List.
Abstract: The RCPGP is an important
tool among a comprehensive set of
measures to help strengthen the Nation
against risks associated with potential
terrorist attacks. DHS/FEMA uses the
information to evaluate applicants’
familiarity with the national
preparedness architecture and identify
how elements of this architecture have
been incorporated into regional/state/
local planning, operations, and
investments.
Affected Public: State, Local or Tribal
Government.
Estimated Number of Respondents:
10.
Frequency of Response: On occasion.
Estimated Average Hour Burden per
Respondent: 176.2 hours.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
Estimated Total Annual Burden
Hours: 1,762 hours.
Estimated Cost: There is no annual
reporting recordkeeping cost associated
with this collection.
Dated: March 2, 2010.
Larry Gray,
Director, Office of Records Management,
Office of Management, Federal Emergency
Management Agency, Department of
Homeland Security.
[FR Doc. 2010–5854 Filed 3–16–10; 8:45 am]
BILLING CODE 9111–46–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2009–0001]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request, OMB No.
1660–NEW; Radiological Emergency
Preparedness Program Alert and
Notification Phone Survey
AGENCY: Federal Emergency
Management Agency, DHS.
ACTION: Notice; 30-day notice and
request for comments; new information
collection; OMB No. 1660–NEW; FEMA
Form 111, Radiological Emergency
Preparedness Program Alert and
Notification Phone Survey.
SUMMARY: The Federal Emergency
Management Agency (FEMA) has
submitted the information collection
abstracted below to the Office of
Management and Budget for review and
clearance in accordance with the
requirements of the Paperwork
Reduction Act of 1995. The submission
describes the nature of the information
collection, the categories of
respondents, the estimated burden (i.e.,
the time, effort and resources used by
respondents to respond) and cost, and
the actual data collection instruments
FEMA will use.
DATES: Comments must be submitted on
or before April 16, 2010.
ADDRESSES: Submit written comments
on the proposed information collection
to the Office of Information and
Regulatory Affairs, Office of
Management and Budget. Comments
should be addressed to the Desk Officer
for the Department of Homeland
Security, Federal Emergency
Management Agency, and sent via
electronic mail to
oira.submission@omb.eop.gov or faxed
to (202) 395–5806.
E:\FR\FM\17MRN1.SGM
17MRN1
Agencies
[Federal Register Volume 75, Number 51 (Wednesday, March 17, 2010)]
[Notices]
[Pages 12769-12770]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-5767]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Complementary and Alternative Medicine
Announcement of Workshop on Control/Comparison Groups for Trials of
Non-Pharmacologic Interventions
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Center for Complementary and Alternative Medicine
(NCCAM) invites the public to participate at a Workshop on the choice
of control and comparison groups for trials of non-pharmacological
interventions (NPI). The purpose of this workshop is to review the
strengths and weaknesses of the various control/comparison groups used
in studies of NPI and the most appropriate use of these control/
comparison groups. This workshop will be divided into six sessions that
will feature presentations and discussions focusing on the selection of
a particular control/comparison group(s) for a given research question.
The first session will provide case studies from the NPI literature,
while the remainder will address the choice of control/comparison
groups when researching the following questions: What is/are the major
active component(s) of the NPI? What is/are the major effective
mechanism(s) of the NPI? Does this NPI work at all? Is this NPI as good
as (or better than) some other intervention? Does this NPI improve
standard-of-care?
[[Page 12770]]
The Workshop will take place on April 26-27, 2010 in Rockville,
Maryland. Seating is limited.
Background: The National Center for Complementary and Alternative
Medicine (NCCAM) was established in 1998 with the mission of exploring
complementary and alternative healing practices in the context of
rigorous science, training CAM researchers, and disseminating
authoritative information to the public and professionals.
To date, NCCAM's efforts to rigorously study CAM, to train CAM
researchers, and to communicate with the public and professionals, have
been guided by NCCAM's previous strategic plans, located on the NCCAM
Web site at https://nccam.nih.gov/about/plans.
The Workshop will take place on April 26-27, 2010 in Rockville,
Maryland. Seating is limited.
FOR FURTHER INFORMATION CONTACT: To request more information, visit the
NCCAM Web site at https://nccam.nih.gov, call Edward Culhane at 301-594-
3391, or e-mail culhanee@mail.nih.gov.
Dated: March 9, 2010.
Richard Nahin,
Senior Advisor for Scientific Coordination and Outreach, National
Center for Complementary and Alternative Medicine, National Institutes
of Health.
[FR Doc. 2010-5767 Filed 3-16-10; 8:45 am]
BILLING CODE 4140-01-P